Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3331 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3331, RRID:AB_2265057
- Product name
- Phospho-Jak1 (Tyr1034/1035) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Storage
- -20°C
Submitted references CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells.
SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Zhang WN, Wang L, Wang Q, Luo X, Fang DF, Chen Y, Pan X, Man JH, Xia Q, Jin BF, Li WH, Li T, Liang B, Chen L, Gong WL, Yu M, Li AL, Zhou T, Li HY
The Journal of biological chemistry 2012 Jan 2;287(1):382-92
The Journal of biological chemistry 2012 Jan 2;287(1):382-92
Hepatocyte growth factor suppresses the anticancer effect of irinotecan by decreasing the level of active metabolite in HepG2 cells.
Okumura M, Iwakiri T, Takagi A, Hirabara Y, Kawano Y, Arimori K
Biochemical pharmacology 2011 Dec 1;82(11):1720-30
Biochemical pharmacology 2011 Dec 1;82(11):1720-30
SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z, Bradner JE, Greenberg E, Levine R, Foster R, Mahoney J, Seiden MV
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 15;12(22):6844-52
Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 15;12(22):6844-52
No comments: Submit comment
No validations: Submit validation data